Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Pasadena
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Pasadena, TX

Studies commonly pay $75 to $4,500 per completed study

3,014 clinical trials are currently recruiting participants within 30 miles of Pasadena. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

3,014studies recruiting
9+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Pasadena right now

Top 25 of 3,014 recruiting studies, sorted by proximity — each links to its official registry page

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Phase 2 Interventional 270 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: M.D. Anderson Cancer Center

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: American Society of Clinical Oncology

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Phase 1 Interventional 604 participants sought
University of Texas, MD Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: Revolution Medicines, Inc.

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center — Houston, Texas (14.7 mi) · Sponsor: National Cancer Institute (NCI)

Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

Lymphedema, Fibrosis Phase 2 Interventional 295 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: M.D. Anderson Cancer Center

Advancing Discussions Using a Video-based Support Tool About End-of-life Care

Traumatic Injury N/A Interventional 270 participants sought
The University of Texas Health Science Center at Houston — Houston, Texas (14.7 mi) · Sponsor: The University of Texas Health Science Center, Houston

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

Hematologic Malignancies Phase 2 Interventional 35 participants sought
The University of Texas M. D. Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: M.D. Anderson Cancer Center

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Retina Consultants of Texas-Bellaire-67493 — Bellaire, Texas (18.8 mi) · Sponsor: Boehringer Ingelheim

Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease EARLY/Phase 1 Interventional 24 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: M.D. Anderson Cancer Center

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Advanced Solid Tumors Phase 1, Phase 2 Interventional 83 participants sought
The University of Texas MD Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic

Spinal Cord Injury, Pressure Injury N/A Interventional 808 participants sought
Michael E. DeBakey VA Medical Center, Houston, TX — Houston, Texas (14.7 mi) · Sponsor: VA Office of Research and Development

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

Herpes Zoster (HZ), Vascular Dementia N/A Observational 375 participants sought
Center for Clinical Studies, LTD. LLP — Webster, Texas (8.5 mi) · Sponsor: Center for Clinical Studies, Texas

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Obesity and Diabetes Mellitus, Type 2, Diabetes Prevention N/A Interventional 30 participants sought
Children's Nutrition Research Center — Houston, Texas (14.7 mi) · Sponsor: Baylor College of Medicine

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Houston, Texas (14.7 mi) · Sponsor: AstraZeneca

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Advanced Solid Tumor Phase 1 Interventional 105 participants sought
The University of Texas Md Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: BeOne Medicines

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Low Grade Ovarian Serous Adenocarcinoma, Malignant Ovarian Neoplasm N/A Observational 2,000 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: M.D. Anderson Cancer Center

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

IDH1 wt Allele, Recurrent Anaplastic Astrocytoma Phase 1 Interventional 36 participants sought
M D Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: M.D. Anderson Cancer Center

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Texas Children's Hospital — Houston, Texas (14.7 mi) · Sponsor: Nationwide Children's Hospital

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

Airway Complication of Anesthesia N/A Observational 10,500 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: University of Turin, Italy

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma Phase 1 Interventional 168 participants sought
MD Anderson Cancer Center — Houston, Texas (14.7 mi) · Sponsor: OncoNano Medicine, Inc.

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Obesity and Type 2 Diabetes N/A Interventional 40 participants sought
USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine — Houston, Texas (14.7 mi) · Sponsor: Baylor College of Medicine
Actively enrolling

Studies you may be able to join near Pasadena

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Pasadena

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Advanced Clinical Research Center of Houston

★ 4.0
1051 Pineloch Dr #600, Houston, TX 77062
(832) 284-4343

Tranquil Clinical Research - Phase 1

★ 5.0
16969 N Texas Ave Ste 600, Webster, TX 77598
(713) 907-6054
"The tranquil Clinic team is completely amazing I feel so comfortable coming here during my visits everything person here is part of the puzzle of per…"
— Gabriel Abad, 5★

Accurate Clinical Research

★ 1.0
11003 Resource Pkwy, Houston, TX 77089
(281) 481-8557
"Signed up for a study before Thanksgiving. Jada said she would be in contact the week of Thanksgiving to let me know if I met the criteria. It is now…"
— Brandi Womack, 1★

Center For Clinical Studies

★ 4.0
451 N Texas Ave, Webster, TX 77598
(281) 343-3300

Unite Clinical Research Consortium

1115 Gemini St Ste 112, Houston, TX 77058
(917) 526-0527

Vilo Research Group Inc

★ 4.9
3100 Broadway St #105F, Houston, TX 77017
(832) 821-1515
"I loved this place, I highly recommend it. They have excellent service, I give it 100 out of 10."
— Georky Díaz Mena, 5★

Spring Clinical Research

★ 4.4
2000 Crawford St Ste 1125, Houston, TX 77002
(281) 888-5564

Webster Clinical Trials

290 E Medical Center Blvd #1, Webster, TX 77598
(832) 478-4171

Center for Clinical Studies

★ 5.0
1401 Binz St Unit 200, Houston, TX 77004
(281) 343-3300

Clinical trials in Pasadena: what's recruiting

The Pasadena area currently has 3,014 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Pasadena, the most active research areas are:

  • Cancer & Oncology13 studies
  • Diabetes & Metabolism3 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Pasadena, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Pasadena

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Pasadena participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Pasadena?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Pasadena safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Pasadena, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Pasadena?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Pasadena.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Pasadena typically complete one or two studies per year.

Paid clinical trials near Pasadena

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of TX

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts